Figure 5
From: The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
Correlation of p65 and PKD1 expression in human PDA.
(A) Serial sections that show a representative of 20 different patient tissue samples that were stained by H&E or IHC for expression of PKD1 or p65. Shown is a representative lesion area. The bar indicates 100 μm. (B) Shows a representative of 20 different patient tissue samples that were co-stained by IHC-IF for PKD1 (red) or phospho-S536-p65 (green). Shown is a representative lesion area. The bar indicates 100 μm. (C) Relative expression of PKD1 and pS536-p65 in n = 20 patient samples. The quantitation analysis is described in Materials & Methods.
